FDA's first DQSA track-and-trace workshop will be held May 8-9
First of many meetings to come that are required by the Drug Supply Chain Security Act
FDA has posted a Federal Register announcement of a public workshop to be held May 8-9 at its Silver Spring, MD, campus. This is the first of many meetings that are specified in Title II of the Drug Quality and Security Act passed last November (Title II is being called the Drug Supply Chain Security Act, or DSCSA, by FDA).
The subject of the meeting is: “Standards for the Interoperable Exchange of Information for Tracing of Human, Finished, Prescription Drugs, in Paper or Electronic Format,” which refers, at one level, to how barcode information on drugs are to be incorporated into packaging, and at another level to a trio of regulatory items, “Transaction Information,” “Transaction History” and “Transaction Statement,” that are the documentation of product movement through supply chains. FDA has had a docket open since February soliciting comments on these topics.
Registration information is available here.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
